Physician-Scientist Ravi Thadhani, MD, MPH, Named AAAS Fellow

BYLINE: Cara Martinez

Newswise — LOS ANGELES (March 26, 2026) — Ravi Thadhani, MD, MPH, executive vice president of Clinical Affairs and chief medical officer for Cedars-Sinai Medical Center and Cedars-Sinai Health System, has been elected a Fellow of the American Association for the Advancement of Science (AAAS).

The organization, one of the world’s largest general scientific societies and publisher of the Science family of journals, has awarded fellowships since 1874.

The distinguished lifetime honor recognizes Thadhani’s pioneering work in the field of nephrology and in the study of preeclampsia, a leading cause of maternal and perinatal morbidity and mortality. He played a leading role in developing the first Food and Drug Administration-approved test to predict preeclampsia.

“Dr. Thadhani is an internationally respected leader in clinical and translational research,” said Peter L. Slavin, MD, president and CEO of Cedars-Sinai Medical Center and Cedars-Sinai Health System. “His visionary work strengthens Cedars-Sinai and extends beyond our healthcare system to the broader medical and research community.”

Thadhani is among nearly 500 scientists, engineers and innovators who have been elected a 2025 Fellow for their scientifically and socially distinguished achievements throughout their careers.

Thadhani joins the ranks of several Cedars-Sinai faculty who have been honored, with the most recent being Shlomo Melmed, MB, ChB, executive vice president of Medicine and Health Sciences and dean of the Medical Faculty at Cedars-Sinai, who was elected in 2025.

“I feel immensely grateful to have a career dedicated to serving patients and science,” Thadhani said. “My work and life have been enriched by the countless mentors, colleagues, trainees and mentees who have collaborated alongside me—people and experiences for which I am deeply thankful.”

Thadhani began his career at Massachusetts General Hospital and Harvard Medical School. He served as vice dean for Research and Education at Cedars-Sinai Medical Center from 2017 to 2019, then returned to Harvard as professor of Medicine and chief academic officer, and dean for Faculty Affairs at Mass General Brigham.

In 2022, Thadhani was named executive vice president for Health Affairs at Emory University, vice chair of the Emory Healthcare Board of Directors and executive director of Emory’s Woodruff Health Sciences Center, which includes Emory’s schools of medicine, public health and nursing.

He returned to Cedars-Sinai in October 2025, rejoining the team involved in this research: Anders Berg, MD, PhD, vice chair of Clinical Pathology; S. Ananth Karumanchi, MD, professor of Medicine and director of the Renovascular Research Center; and Sarah J. Kilpatrick, MD, PhD, chair of the Department of Obstetrics and Gynecology.

Shortly after his return to Cedars-Sinai, Thadhani was elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.

He has been inducted into several additional honor societies, including the American Society for Clinical Investigation, the Association of American Physicians, the American Epidemiological Society, and the American Clinical and Climatological Association.

Thadhani is the author or co-author of more than 300 scientific manuscripts that have been published in The New England Journal of Medicine, The Lancet, the Journal of the American Medical Association and other top-tier academic journals.

Cedars-Sinai Health Sciences University is advancing groundbreaking research and educating future leaders in medicine, biomedical sciences and allied health sciences. Learn more about the university.